S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
CVE:EPI

ESSA Pharma Stock Forecast, Price & News

C$8.20
+0.55 (+7.19 %)
(As of 10/30/2020)
Add
Compare
Today's Range
C$7.33
C$8.20
50-Day Range
C$8.20
C$8.20
52-Week Range
C$4.00
C$11.34
Volume1,430 shs
Average Volume4,834 shs
Market CapitalizationC$237.87 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive EPI News and Ratings via Email

Sign-up to receive the latest news and ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter.


About ESSA Pharma

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
25
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$2.21 per share
Book Value
C$2.21 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
C$237.87 million
Next Earnings Date
N/A
Optionable
Optionable

MarketRank

Overall MarketRank

0.96 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












ESSA Pharma (CVE:EPI) Frequently Asked Questions

What stocks does MarketBeat like better than ESSA Pharma?

Wall Street analysts have given ESSA Pharma a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ESSA Pharma wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has ESSA Pharma's stock price been impacted by COVID-19?

ESSA Pharma's stock was trading at C$5.56 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, EPI stock has increased by 47.5% and is now trading at C$8.20.
View which stocks have been most impacted by COVID-19
.

Is ESSA Pharma a good dividend stock?

ESSA Pharma pays an annual dividend of C$0.22 per share and currently has a dividend yield of 0.00%.

Who are ESSA Pharma's key executives?

ESSA Pharma's management team includes the following people:
  • Dr. David Ross Parkinson, Pres, CEO & Director (Age 71, Pay $626.81k)
  • Mr. David S. Wood C.M.A., CPA, M.B.A., MBA, CPA, CMA, Chief Financial Officer (Age 64, Pay $311.52k)
  • Mr. Peter A. Virsik M.B.A., M.S., Exec. VP & COO (Age 50, Pay $544.66k)
  • Dr. Alessandra Cesano, Chief Medical Officer
  • Chandtip Chandhasin, Exec.
  • Erica Osbourne, Exec.
  • Erin Rudsinski, Exec.
  • Leah Dimascio, Exec.
  • Loleta Harris, Exec.
  • Neil Thapar, Exec.

What other stocks do shareholders of ESSA Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ESSA Pharma investors own include Aurora Cannabis (ACB), Air Canada (AC), Arbutus Biopharma (ABUS), AB Science (ABSCF), AB International Group (ABQQ), AB Dynamics (ABDP), Advantage Energy (AAV), AA (AATDF), AAON (AAON) and AAC Technologies (AACAY).

What is ESSA Pharma's stock symbol?

ESSA Pharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EPI."

How do I buy shares of ESSA Pharma?

Shares of EPI and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is ESSA Pharma's stock price today?

One share of EPI stock can currently be purchased for approximately C$8.20.

How much money does ESSA Pharma make?

ESSA Pharma has a market capitalization of C$237.87 million.

How many employees does ESSA Pharma have?

ESSA Pharma employs 25 workers across the globe.

What is ESSA Pharma's official website?

The official website for ESSA Pharma is essapharmaceuticals.com.

Where are ESSA Pharma's headquarters?

How can I contact ESSA Pharma?

ESSA Pharma's mailing address is 999 Broadway W Suite 720, VANCOUVER, BC V5Z 1K5, Canada. The company can be reached via phone at +1-778-3310962.


This page was last updated on 10/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.